Literature DB >> 91421

Kinetics of 57Co-bleomycin in mice after intravenous, subcutaneous and intratumoral injection.

J Bier, P Benders, M Wenzel, K Bitter.   

Abstract

In tumor-free and tumor-bearing mice the body clearance and organ distribution of 57Co-BLM was measured in different time intervals after iv, sc, and it administration of the drug. No significant differences could be demonstrated in body clearances following different doses and routes of application of labeled BLM in tumor-free and tumor-bearing mice. The organ distribution studies showed higher concentrations following iv compared to sc or it application of 57Co-BLM; however, the activity in the ipsilateral injection sites were significantly increased after sc and it injection. In tumor-bearing mice the activity in the draining lymph nodes of the injection site were as high as that seen in draining lymph nodes following iv injection. However, on the contralateral side, the lymph node concentration was significantly reduced after it injection. These results indicate on the basis of organ distribution of 57Co-BLM a rational basis for it treatment of malignant tumors.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 91421     DOI: 10.1002/1097-0142(197910)44:4<1194::aid-cncr2820440405>3.0.co;2-z

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

Review 1.  Drug delivery to solid tumors by elastin-like polypeptides.

Authors:  Jonathan R McDaniel; Daniel J Callahan; Ashutosh Chilkoti
Journal:  Adv Drug Deliv Rev       Date:  2010-05-27       Impact factor: 15.470

2.  Intratumoural administration of cisplatin in slow-release devices. I. Tumour response and toxicity.

Authors:  M J Deurloo; S Bohlken; W Kop; C F Lerk; W Hennink; H Bartelink; A C Begg
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

3.  Injectable intratumoral depot of thermally responsive polypeptide-radionuclide conjugates delays tumor progression in a mouse model.

Authors:  Wenge Liu; J Andrew MacKay; Matthew R Dreher; Mingnan Chen; Jonathan R McDaniel; Andrew J Simnick; Daniel J Callahan; Michael R Zalutsky; Ashutosh Chilkoti
Journal:  J Control Release       Date:  2010-01-31       Impact factor: 9.776

4.  Protein-Engineered Nanoscale Micelles for Dynamic 19F Magnetic Resonance and Therapeutic Drug Delivery.

Authors:  Lindsay K Hill; Joseph A Frezzo; Priya Katyal; Dung Minh Hoang; Zakia Ben Youss Gironda; Cynthia Xu; Xuan Xie; Erika Delgado-Fukushima; Youssef Z Wadghiri; Jin Kim Montclare
Journal:  ACS Nano       Date:  2019-02-19       Impact factor: 15.881

5.  Regional chemotherapy in an experimental model of Wilms' tumor in rats.

Authors:  P M Andrews; C L Johnson
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

6.  Sustained release chemotherapeutic microspheres provide superior efficacy over systemic therapy and local bolus infusions.

Authors:  Dwaine F Emerich; Pamela Snodgrass; Denise Lafreniere; Reginald L Dean; Heather Salzberg; Joanne Marsh; Brigido Perdomo; Mahin Arastu; Shelley R Winn; Raymond T Bartus
Journal:  Pharm Res       Date:  2002-07       Impact factor: 4.200

7.  Intratumoural administration of cisplatin in slow-release devices: II. Pharmacokinetics and intratumoural distribution.

Authors:  M J Deurloo; W Kop; O van Tellingen; H Bartelink; A C Begg
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.